Antibody-drug Conjugates (ADC)

Azetidine-3-carboxylic acid serves as a non-cleavable linker for the synthesis of antibody-drug conjugates (ADCs). Its unique structure is also applicable as an alkyl chain-based PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs). This compound enhances the stability and functionality of bioconjugates, making it valuable for targeted therapeutic research and development.

N-(5-Hydroxypentyl)maleimide serves as a non-cleavable linker in antibody-drug conjugate (ADC) synthesis. This reagent facilitates the stable attachment of drugs to antibodies, ensuring effective delivery in targeted therapies. It is particularly useful in the development of ADCs such as Gemcitabine-O-Si(di-iso)-O-Mc, enhancing their therapeutic potential in cancer research.

Propargyl-PEG8-NH2 is a PEG-based linker primarily used in antibody-drug conjugates (ADCs) and PROTAC synthesis. This non-cleavable linker enhances the stability of ADCs while facilitating the targeted delivery of therapeutic agents. Additionally, its alkyne functional group allows for copper-catalyzed azide-alkyne cycloaddition (CuAAc), making it a valuable tool in click chemistry applications for bioconjugation and drug development.

Boc-NH-ethyl-SS-propionic acid is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound enables the selective release of cytotoxic agents within targeted cells, enhancing therapeutic efficacy while minimizing off-target effects. Its unique structure facilitates controlled cleavage, making it an essential component in the development of innovative cancer therapies.

m-PEG6-Amine is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and antibody-drug conjugates (ADCs). This cleavable linker enhances the stability and delivery of therapeutic agents, enabling targeted degradation of specific proteins within cellular systems. m-PEG6-Amine applications include the development of innovative ADCs for cancer therapy and other therapeutic modalities that require precise protein modulation.

11-Azidoundecanoic acid is a click chemistry reagent characterized by its azide functional group, primarily acting as a substrate for lipoic acid ligase (LpIA). This compound facilitates bioconjugation and can be modified through Staudinger ligation or click-chemistry techniques. It also supports copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, in addition to enabling strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN functionalized partners. 11-Azidoundecanoic acid is valuable in research applications requiring precise labeling and bioconjugation strategies.

Biotin-PEG1-azide is a cleavable PEG-based linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functional group, allowing for efficient coupling through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, Biotin-PEG1-azide can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions when interacting with DBCO or BCN moieties, facilitating versatile labeling and conjugation strategies in chemical biology and therapeutic applications.

(4S)-4-Hydroxy-D-proline methyl ester hydrochloride functions as a non-cleavable linker in the development of antibody-drug conjugates (ADCs). This compound exhibits key biological activity by facilitating stable covalent attachment between antibodies and cytotoxic agents, enhancing the therapeutic efficacy of ADCs. Additionally, its alkyl chain structure allows for application as a PROTAC linker, aiding in the design and synthesis of proteolysis-targeting chimeras.

PTDA-PEG4-azide is a cleavable 4 unit polyethylene glycol (PEG) linker designed for the construction of antibody-drug conjugates (ADCs). This linker contains an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, PTDA-PEG4-azide can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules featuring DBCO or BCN groups, making it a versatile tool in chemical biology and drug development applications.

N3-PEG4-C2-Pfp ester is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This 4-unit PEG linker features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-bearing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN-containing compounds, making it a versatile choice for bioconjugation applications in chemical biology and drug development.

Boc-Val-Ala-PAB is a cathepsin-cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of therapeutic agents by linking them to monoclonal antibodies, enhancing the selectivity and efficacy of treatment. Its application in ADC development supports research in cancer therapies and targeted drug delivery systems.

Aminoethyl-SS-propionic acid is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates the attachment of therapeutic agents to monoclonal antibodies, enabling targeted delivery of cytotoxic drugs to cancer cells. Its unique properties ensure stability in circulation while allowing for controlled release in the tumor microenvironment, making it a valuable tool for cancer research and drug development.

Bis-PEG9-acid is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound features a cleavable structure, making it suitable for the development of antibody-drug conjugates (ADCs). Its unique properties facilitate targeted degradation of proteins, enabling efficient research in drug discovery and therapeutic development.

Azido-PEG4-CH2-Boc functions as a cleavable linker primarily utilized in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This versatile reagent incorporates a PEG spacer and an azide group, allowing it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions. Its effective application in the development of novel bioconjugates and protein degradation-based therapeutic strategies makes it a valuable tool in chemical biology and drug development research.

PL1601 (BCN-HS-PEG2-VA-PABC-SG3199) is a versatile drug linker designed for antibody-drug conjugates (ADCs). This compound features a BCN group that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling efficient conjugation. Its application in click chemistry enhances the specificity and efficacy of targeted drug delivery systems in various biological research contexts.

diMal-O-CH2COOH is a cleavable ADC linker that facilitates the effective delivery of therapeutic agents to targeted cells. This compound plays a crucial role in antibody-drug conjugates by enhancing the stability and bioavailability of the drug while promoting selective release in the tumor microenvironment. Its unique chemical structure enables efficient conjugation and subsequent cleavage, making it an essential tool for research in targeted cancer therapies.

Biotin-C4-amide-C5-NH2 serves as a cleavable linker for the assembly of antibody-drug conjugates (ADCs). This compound facilitates targeted delivery of cytotoxic agents, enhancing the therapeutic efficacy of ADCs while minimizing off-target effects. Its biotin functionality allows for versatile conjugation strategies, making it a valuable tool in the development of innovative cancer therapies and related research applications.

PC Mal-NHS carbonate ester functions as a cleavable linker in the development of antibody-drug conjugates (ADCs). Its primary activity lies in facilitating the selective attachment of cytotoxic agents to monoclonal antibodies, allowing for targeted delivery to cancer cells. This compound is essential for advancing research in targeted therapies and improving the efficacy of cancer treatments.

NH2-PEG5-OH is a PEG-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) and antibody-drug conjugates (ADCs). This non-cleavable linker, incorporating a five-unit polyethylene glycol (PEG) structure, enhances the stability and solubility of biologically active compounds. Researchers utilize NH2-PEG5-OH to facilitate targeted degradation of proteins or deliver cytotoxic agents via ADCs, improving therapeutic efficacy in various applications.

Zuvotolimod is an innovative myeloid cell agonist designed as a compound-linker for antibody-drug conjugates (ADCs). This reagent enhances the efficacy of targeted therapies by promoting immune activation in the tumor microenvironment. Zuvotolimod is valuable in cancer research and the study of hepatitis, facilitating investigations into immune modulation and therapeutic interventions.

Fmoc-Gly-Gly-D-Phe-OH is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound serves as a critical component in the development of targeted therapeutics, facilitating the attachment of cytotoxic agents to antibodies. Fmoc-Gly-Gly-D-Phe-OH exhibits enhanced stability during circulation and selective release of the active drug in target tissues, making it valuable for cancer research and drug delivery applications.

Phe-Lys(Fmoc)-PAB is a cathepsin-cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic payloads upon internalization, enhancing therapeutic efficacy. Its application is particularly valuable in targeted cancer therapies, where precise control over drug release is crucial for minimizing off-target effects and improving patient outcomes.

N3-PEG3-CH2CH2-Boc is a cleavable linker designed for use in PROTAC synthesis, specifically serving as a 3-unit polyethylene glycol (PEG) intermediary. This compound facilitates the formation of antibody-drug conjugates (ADCs) and supports click chemistry applications through its azide group. It readily participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-functionalized molecules and can also engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups, proving valuable in diverse chemical research applications.

1-Cbz-3-Hydroxyazetidine is a non-cleavable ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). Its structural features facilitate stability and efficacy in targeted drug delivery systems. Additionally, this compound serves as an alkyl chain-based PROTAC linker, making it valuable in the development of proteolysis-targeting chimeras (PROTACs) for enhanced protein degradation studies.

Propargyl-PEG1-SS-PEG1-acid is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound features an alkyne group enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc), facilitating efficient conjugation with azide-containing molecules. Its unique structure and properties make it a valuable tool for researchers involved in the development of targeted therapeutics.

Propargyl-PEG6-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based reagent features an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc), facilitating the conjugation of biomolecules. Its versatility as a click chemistry reagent enhances the development of targeted therapies in chemical biology and drug discovery applications.

Fmoc-N-(2-Boc-aminoethyl)-Gly-OH is a Fmoc-protected glycine derivative designed for use as a linker in antibody-drug conjugate (ADC) synthesis. This reagent facilitates the conjugation of antibodies with cytotoxic agents, enabling targeted delivery of therapeutic compounds. Its structural features make it suitable for various applications in bioconjugation and drug development research.

Fmoc-Hyp(Bom)-OH is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a unique structure that promotes effective conjugation while maintaining stability in biological systems. Additionally, Fmoc-Hyp(Bom)-OH can serve as an alkyl chain-based linker for the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation studies. Its versatile applications make it an essential tool for researchers in the fields of drug development and chemical biology.

DBCO-PEG3-acid is a non-cleavable ADC linker featuring a 3-unit polyethylene glycol (PEG) chain. Its primary mechanism involves the strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling effective conjugation in the synthesis of antibody-drug conjugates (ADCs). This reagent is particularly valuable in therapeutic research applications, facilitating targeted drug delivery and enhancing the pharmacological properties of antibody-based treatments.

PPC-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of cytotoxic agents to antibodies, enabling targeted delivery and enhancing therapeutic efficacy. Its specific reactivity allows for the stable attachment of drugs while ensuring release under appropriate conditions, making it valuable for development in cancer therapeutics and targeted treatment strategies.

Docosanedioic acid functions as a non-cleavable linker in the development of antibody-drug conjugates (ADCs). Its elongated alkyl chain structure provides robust stability, making it suitable for conjugating therapeutic agents to antibodies. Additionally, this compound serves as an alkyl chain-based PROTAC linker, facilitating the synthesis of proteolysis-targeting chimeras (PROTACs) for targeted degradation in research applications.

Amino-PEG5-C2-acid is a PEG-based linker designed for use in the synthesis of PROTACs and non-cleavable antibody-drug conjugates (ADCs). This compound facilitates the conjugation of active pharmaceutical ingredients to antibodies, thereby enhancing target specificity and therapeutic efficacy. Its unique structure allows for optimal stability and performance in bioconjugation applications, making it a valuable tool for researchers in drug development and targeted therapy.

Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. This compound enables the controlled release of therapeutic agents, enhancing the efficacy and specificity of targeted cancer treatments. Its structure facilitates stable conjugation while allowing for timely payload delivery upon internalization by target cells. Researchers can utilize this linker in the development of ADCs for improved tumor-targeting strategies in preclinical studies.

H-L-Tyr(2-azidoethyl)-OH hydrochloride is an unnatural tyrosine derivative designed for use in click chemistry applications. Featuring an azide functional group, this reagent is suitable for copper-catalyzed azide-alkyne cycloaddition (CuAAc) with various alkyne-containing molecules. Additionally, it can facilitate ring strain-promoted alkyne-azide cycloaddition (SPAAC) in reactions involving DBCO or BCN groups, making it a versatile tool for bioconjugation and synthetic biology studies.

DBCO-PEG24-Maleimide is a versatile linker featuring a maleimide group and a DBCO (dibenzocyclooctyne) moiety. This compound is ideal for conjugating thiol-containing biomolecules and facilitates efficient click chemistry reactions with azide-bearing substrates. Its unique structure enables stable linkages, making it suitable for applications in antibody-drug conjugates (ADCs) and other bioconjugation frameworks in chemical biology research.

Norbornene-NHS is a versatile click chemistry reagent targeting the site-specific conjugation of biomolecules. As a dienophile, it facilitates copper-free click reactions with tetrazines, enabling efficient and selective labeling and modification. This reagent is ideal for applications in bioconjugation, protein labeling, and the development of advanced materials in chemical research.

H-Asp-Gly-OH is a cleavable ADC linker that enables the selective delivery of therapeutic agents to target cells. This compound demonstrates effective release mechanisms under specific conditions, facilitating the liberation of cytotoxic drugs in targeted therapies. It is widely utilized in the development of antibody-drug conjugates to enhance therapeutic efficacy while minimizing off-target toxicity.

Mal-PEG2-Val-Cit-PABA-PNP is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound features a malemide functionality for thiol conjugation, facilitating the attachment of cytotoxic agents to antibodies. Its PABA-PNP component allows for specific cleavage in the tumor microenvironment, thereby releasing the active drug and enhancing therapeutic efficacy. This linker is suitable for research applications in targeted cancer therapy development and ADC formulation studies.

SNPB is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This linker facilitates the targeted delivery of cytotoxic agents to tumor cells, enhancing therapeutic efficacy while minimizing off-target effects. Its unique chemical properties enable selective cleavage in the tumor microenvironment, making SNPB a valuable tool for advancing ADC research and development.

Amino-PEG4-CH2COOH is a PEG-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) and serves as a non-cleavable four-unit PEG linker for antibody-drug conjugates (ADCs). This compound facilitates the formation of stable conjugates, thereby enhancing the delivery of therapeutic agents to targeted cells. Its unique properties support research applications in targeted protein degradation and ADC development, contributing to advancements in cancer therapy and drug efficacy.

DBCO-PEG4-Val-Ala-PAB-PNP is a cleavable antibody-drug conjugate (ADC) linker designed for targeted delivery applications. The Val-Ala sequence enables selective cleavage by Cathepsin B, facilitating the release of the therapeutic payload. The incorporation of a PEG spacer enhances aqueous solubility, while the DBCO group is suitable for Click Chemistry reactions due to its reactivity. Additionally, the PNP moiety serves as an efficient leaving group, making this compound valuable in bioconjugation and therapeutic development.

Mal-amido-PEG10-C2-NHS ester is a non-cleavable ADC linker featuring a maleimide group and a reactive NHS ester. This compound is designed for the selective labeling of primary amines in proteins, amine-modified oligonucleotides, and other amine-containing molecules. Its versatile application in the development of antibody-drug conjugates (ADCs) facilitates targeted therapeutic strategies in chemical research.

Methyltetrazine-DBCO is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a DBCO group that enables strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Additionally, the inclusion of a tetrazine moiety allows for inverse electron demand Diels-Alder reactions (iEDDA) with trans-cyclooctene (TCO) compounds. Methyltetrazine-DBCO is an essential reagent for researchers developing targeted therapies through click chemistry methodologies.

AEEA-AEEA is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs), facilitating targeted delivery of therapeutic agents. Additionally, this alkyl chain-based linker serves as a versatile component in the construction of PROTACs (proteolysis-targeting chimeras). Its stability and efficacy make it a valuable reagent for advancing cancer research and targeted protein degradation studies.

Mal-amido-PEG5-C2-NHS ester is a non-cleavable ADC linker that features a maleimide moiety and an NHS ester. This reagent effectively conjugates to primary amines (-NH2) found in proteins, amine-modified oligonucleotides, and other amine-containing biomolecules. Its design facilitates the development of antibody-drug conjugates (ADCs) for targeted therapeutics, enabling specific and stable linking of drugs to antibodies for enhanced efficacy in research applications.

NH-bis-PEG2 is a non-cleavable linker featuring a two-unit polyethylene glycol (PEG) structure, primarily utilized in the development of antibody-drug conjugates (ADCs). This PEG-based linker is also applicable in the synthesis of PROTACs, facilitating targeted protein degradation. Its chemical properties allow for improved solubility and stability, making it a valuable tool in drug development and biochemical research.

Hydroxy-PEG6-acid is a PEG-based, non-cleavable linker designed for use in the synthesis of Antibody-Drug Conjugates (ADCs). This reagent enhances the solubility and stability of ADCs while maintaining the integrity of the antibody's targeting capabilities. It is suitable for various research applications, including the development of targeted cancer therapies and exploration of novel drug delivery systems.

Boc-NMe-Val-Val-Dil-Dap-OH is a versatile linker designed for use in antibody-drug conjugate (ADC) synthesis. This compound facilitates the covalent attachment of cytotoxic agents to antibodies, enhancing therapeutic efficacy while minimizing off-target effects. It is particularly useful in the development of targeted cancer therapies, enabling precise delivery of drugs to tumor cells.

NH-bis(C1-Boc) is an uncleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This chemical provides stability during circulation in the bloodstream, ensuring that the drug remains attached to the antibody until it reaches the target site. Its unique characteristics facilitate targeted delivery of cytotoxic agents, enhancing therapeutic efficacy in cancer research and treatment development.

Ethyl azetidine-3-carboxylate hydrochloride functions as a non-cleavable linker for antibody-drug conjugates (ADCs). It is pivotal in the formation of stable ADCs, providing effective delivery of cytotoxic drugs to targeted cancer cells. Additionally, this compound serves as an alkyl chain-based linker in the synthesis of PROTACs, enabling selective degradation of specific proteins in research applications.